Heartstitch, Inc.

Heartstitch, Inc.
About Us
Follow us:
Share:
Subscribe:

About Us

About HeartStitch: HeartStitch®, Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on the innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures. HeartStitch® manufactures and markets the NobleStitch™ EL under and exclusive license from Nobles Medical Technologies II, Inc. NobleStitch™ EL is FDA cleared for vascular suturing in the United States and CE Marked for cardio-vascular suturing and PFO closure in the European Union. HeartStitch® is a registered trademark of HeartStitch®, Inc. For more on HeartStitch® visit www.HeartStitch.com

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Nobles Medical Technologies II Receives Allowance Of Its Groundbreaking Patent For Next-Generation Suturing Device

Fri, May 20, 2016 15:38 CET

NobleStitch™ QP Provides a Running Suture— A Key Element To Close Septal DefectsNobles Medical Technologies II (NMT2) today announced that it has received notice of allowance of its claims for its next-generation suturing technology. With the issuance of this patent, NMT2 will expand its suture technologies to include the ability to remotely perform a running suture. This technology will be applied to NMT2’s ASD-closure project currently under development. Prof. Anthony Nobles, CEO of NMT2 and co-inventor on the allowed patent claims, commented, “This technology, which is

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

About Us

Nobles Medical Technologies II Receives Allowance Of Its Groundbreaking Patent For Next-Generation Suturing Device